Vol.58 No.S-2 October 2010

In vitro and in vivo antibacterial activity of tosufloxacin tosilate hydrate against major causative bacteria of pneumonia and otitis media in pediatric patients

Yoshiko Fukuda, Yoko Sugiura, Harumi Hisada, Naoko Oogake, Yuko Ito, Masahiro Takahata and Junichi Mitsuyama

Jpn. J. Chemother. 58 (S-2): 1-11, 2010

Toxicity studies of tosufloxacin tosilate hydrate in juvenile animals and class effects studies

Shinichi Furubo, Hitoshi Fukuda, Tsukasa Kozaki, Atsushi Akune and Takahiro Sanzen

Jpn. J. Chemother. 58 (S-2): 12-23, 2010

Pharmacokinetics and safety of oral tosufloxacin granule preparation in healthy adult subjects

Keisuke Sunakawa and Hiroshi Mikami

Jpn. J. Chemother. 58 (S-2): 24-31, 2010

An uncontrolled, open label study of 10% tosufloxacin granules in pediatric pneumonia

Satoshi Iwata, Naoichi Iwai, Kazunobu Ouchi, Hiroshi Sakata and Keisuke Sunakawa

Jpn. J. Chemother. 58 (S-2): 32-49, 2010

An uncontrolled, open label study of tosufloxacin granules 10% in pediatric acute otitis media (AOM)

Kenji Suzuki, Yukiko Iino, Fumiyo Kudo, Hidenobu Taiji and Keisuke Sunakawa

Jpn. J. Chemother. 58 (S-2): 50-68, 2010

Population pharmacokinetics and pharmacodynamics of tosufloxacin granules in pediatric infectious diseases

Keisuke Sunakawa, Naoichi Iwai, Satoshi Iwata, Kazunobu Ouchi, Hiroshi Sakata, Kenji Suzuki, Yukiko Iino, Hidenobu Taiji, Fumiyo Kudo and Kenji Nozawa

Jpn. J. Chemother. 58 (S-2): 69-77, 2010

Safety profile of pediatric tosufloxacin

Seiji Hori, Shoichiro Irimajiri†, Norihiko Koido and Keisuke Sunakawa

Jpn. J. Chemother. 58 (S-2): 78-88, 2010